Literature DB >> 8866433

Immunohistochemical study of intracytoplasmic inclusion bodies of the thalamus in myotonic dystrophy.

S Ono1, K Takahashi, F Kanda, Y Fukuoka, K Jinnai, H Kurisaki, S Mitake, T Inagaki, K Nagao.   

Abstract

Intracytoplasmic inclusion bodies of the thalamus in eight patients with myotonic dystrophy (MyD) were studied immunohistochemically. The intracytoplasmic inclusion bodies of the thalamus (thalamic inclusions, TIs) were strongly immunostained with anti-ubiquitin antibody (Ab) and some of them were mildly stained with anti-microtubule associated protein 1 (MAP 1) and anti-MAP 2 antibodies. However, TIs did not react with any of the following: anti-neurofilament protein Ab, anti-tau Ab, anti-paired helical filament Ab, anti-tubulin Abs (alpha and beta), anti-neuron-specific enolase Ab, anti-glial fibrillary acidic protein Ab, anti-synaptophysin Ab, anti-myelin basic protein Ab, anti-actin Ab and anti-phosphorylated epitope of neurofilaments Ab. Thus, our study demonstrates the unique immunohistochemistry of TIs in MyD which differentiates them from other intracytoplasmic inclusions in various neurodegenerative disorders.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8866433     DOI: 10.1016/0022-510x(96)00107-4

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  2 in total

1.  Coexistence of Progressive Supranuclear Palsy With Pontocerebellar Atrophy and Myotonic Dystrophy Type 1.

Authors:  Shunsuke Koga; J Eric Ahlskog; Michael A DeTure; Matt Baker; Shanu F Roemer; Takuya Konno; Rosa Rademakers; Owen A Ross; Dennis W Dickson
Journal:  J Neuropathol Exp Neurol       Date:  2019-05-24       Impact factor: 3.685

2.  Neuropathology does not Correlate with Regional Differences in the Extent of Expansion of CTG Repeats in the Brain with Myotonic Dystrophy Type 1.

Authors:  Kyoko Itoh; Maki Mitani; Kunihiko Kawamoto; Naonobu Futamura; Itaru Funakawa; Kenji Jinnai; Shinji Fushiki
Journal:  Acta Histochem Cytochem       Date:  2010-12-18       Impact factor: 1.938

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.